In 1953, James Watson and Francis Crick determined that DNA was a double helix. In 1977, Cambridge, Massachusetts became the first city to govern the handling of genetic material. And 40 years later, intellectual property rights to a DNA editing system were awarded to Cambridge-based Broad Institute.
Discoveries of this magnitude alter the course of humanity. They also require risk, agility, time and money. The growth of the life sciences industry, coupled with the subsequent surge in demand for lab space, means rents in Massachusetts are at historical highs – and rising.
Cushman & Wakefield’s latest report “Boston BioWatch” discusses how the Greater Boston life science market is a real estate driver.